Partner Content Partner Content Speaker interview MRC Harwell Institute ahead of SMi’s 3D Ce... Speaker interview MRC Harwell Institute
Partner Content Partner Content Interview Released Stefan Przyborski, Chairman for SMi’s 3D ... Interview with Stefan Przyborski
Partner Content Partner Content SMi’s 3D Cell Culture announces key industry speakers and ag... SMi's 3d Cell Culture agenda released
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
